Mirtazapin Bluefish (Mirtazapine)

Mirtazapine, the active ingredient in Mirtazapin Bluefish, is a NaSSA (noradrenergic and specific serotonergic antidepressant) presented as an oral dosage form for oral use. It is prescribed for the treatment of major depressive disorder in adult patients, helping to improve mood, sleep and appetite when other agents are insufficient.

GNH USA supplies Mirtazapin Bluefish as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing consistent quality, regulatory compliance and reliable logistics for cross‑border procurement, backed by a dedicated technical support team.

Mirtazapine is an antidepressant that acts on noradrenergic and serotonergic pathways to treat depressive disorders.

- Major depressive disorder: reduces depressive symptoms and improves overall mood in adult patients.

Mirtazapine may cause a range of adverse reactions, some of which are more frequent than others.

Common Side Effects: - Sedation or drowsiness - Increased appetite and weight gain - Dry mouth

Serious or Rare Side Effects: - Severe neutropenia - Serotonin syndrome when combined with other serotonergic agents - Marked hypotension

Before initiating therapy, clinicians should consider several safety measures. - Assess hepatic function before initiating therapy: monitor liver enzymes in patients with liver disease. - Monitor weight and metabolic parameters: counsel patients on diet and exercise. - Evaluate for suicidal ideation: especially during early treatment. - Avoid abrupt discontinuation: taper dose under medical supervision. - Store at room temperature: keep in the original container, protect from moisture and light.

Mirtazapine can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Concurrent use with MAO inhibitors: risk of hypertensive crisis. - Combination with potent CYP2D6 inhibitors: may increase plasma levels. - Co‑administration with other serotonergic agents: risk of serotonin syndrome.

Moderate Interactions (Monitor Closely): - Use with CNS depressants: may enhance sedation. - Concurrent antihypertensive therapy: may potentiate blood pressure lowering. - Combination with carbamazepine: may reduce mirtazapine exposure.